Journal
DRUG METABOLISM REVIEWS
Volume 43, Issue 4, Pages 440-456Publisher
INFORMA HEALTHCARE
DOI: 10.3109/03602532.2011.615320
Keywords
Drug metabolism; atypical kinetics; allosterism; substrate inhibition; CYPs; UGTs; SULTs; glucuronidation; sulfonation
Categories
Ask authors/readers for more resources
Inhibition of enzyme activity at high substrate concentrations, so-called substrate inhibition, is commonly observed and has been recognized in drug metabolism reactions since the last decade. Although the importance of such atypical kinetics in vivo remains poorly understood, a substrate with substrate inhibition kinetics has been shown to unconventionally alter the metabolism of other substrates. In recent years, it is becoming increasingly evident that the mechanisms for substrate inhibition are highly complex, which are possibly contributed by multiple (at least two) binding sites within the enzyme protein, the formation of a ternary dead-end enzyme complex, and/or the ligand-induced changes in enzyme conformation. This review primarily discusses the mechanisms for substrate inhibition displayed by the important drug-metabolizing enzymes, such as cytochrome p450s, UDP-glucuronyltransferases, and sulfotransferases. Kinetic modeling of substrate inhibition in the absence or presence of a modifier is another central issue in this review because of its importance in the determination of kinetic parameters and in vitro/in vivo predictions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available